3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
2
Sarcoma, Ewing
1
Patient Compliance
1
Pathologic Complete Response
1
Osteosarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
Methotrexate
3
Ifosfamide
3
Cisplatin
3
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Electroacupuncture
2
Doxorubicin
2
sargramostim
1
regorafenib
1
delta 24-sterol reductase
1
apatinib
1
Tissue and Organ Procurement
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Resistance Training
1
Radiotherapy, Image-Guided
1
Proton Therapy
1
Positron Emission Tomography Computed Tomography
1
Physical Therapy Modalities
1
Pentetic Acid
1
Palliative Care
1
Nutritional Support
1
Neuropsychological Tests
1
Neoadjuvant Therapy
1
Minocycline
1
Mesna
1
Heparin
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Glutamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Osteosarcoma
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled